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Abstract
Background: The calcium-permeable cation channel TRPM8 (melastatin-related transient receptor potential member 
8) is over-expressed in several cancers. The present study aimed at investigating the expression, function and potential 
regulation of TRPM8 channels by ER alpha (estrogen receptor alpha) in breast cancer.
Methods: RT-PCR, Western blot, immuno-histochemical, and siRNA techniques were used to investigate TRPM8 
expression, its regulation by estrogen receptors, and its expression in breast tissue. To investigate the channel activity in 
MCF-7 cells, we used the whole cell patch clamp and the calcium imaging techniques.
Results: TRPM8 channels are expressed at both mRNA and protein levels in the breast cancer cell line MCF-7. Bath 
application of the potent TRPM8 agonist Icilin (20 μM) induced a strong outwardly rectifying current at depolarizing 
potentials, which is associated with an elevation of cytosolic calcium concentration, consistent with established TRPM8 
channel properties. RT-PCR experiments revealed a decrease in TRPM8 mRNA expression following steroid deprivation 
for 48 and 72 hours. In steroid deprived medium, addition of 17-beta-estradiol (E2, 10 nM) increased both TRPM8 mRNA 
expression and the number of cells which respond to Icilin, but failed to affect the Ca2+ entry amplitude. Moreover, 
silencing ERα mRNA expression with small interfering RNA reduced the expression of TRPM8. Immuno-histochemical 
examination of the expression of TRPM8 channels in human breast tissues revealed an over-expression of TRPM8 in 
breast adenocarcinomas, which is correlated with estrogen receptor positive (ER+) status of the tumours.
Conclusion: Taken together, these results show that TRPM8 channels are expressed and functional in breast cancer 
and that their expression is regulated by ER alpha.
Background
Breast cancer is the most common form of cancer in
women in industrialized countries. Clinical and experi-
mental data have revealed that female steroid hormones
play an essential role in the development of sporadic
breast cancer [1]. For example, the steroid hormone 17-β-
estradiol (E2) is involved in the regulation of growth and
differentiation of malignant breast epithelial cells [2]. The
predominant biological effect of E2 is mediated through
its interaction with two intracellular estrogen receptors
(ERα and ERβ), ERα being strongly expressed in 80% of
breast cancers [2-4]. ERs are ligand-dependent transcrip-
tion factors controlled by E2, and they regulate the
expression of many genes [1-5] including potassium [6],
calcium [7,8] and TRP (transient receptor potential)
channels [9,10].
Recently, TRP channels have emerged as new channels
implicated in carcinogenesis [11-14]. In our laboratory,
we have previously shown that TRPC6 (canonical-related
TRP member 6) channels are over-expressed and func-
tional in breast cancer [15]. More recently, we have
shown that TRPM7 (melastatin-related TRP member 7)
is involved in breast cancer cell proliferation [16]. In addi-
tion, TRPM8 (melastatin-related TRP member 8) channel
is found to be over-expressed in several primary tumours
including colon, lung, skin, and prostate cancer [17].
TRPM8 channel is a Ca2+-permeable cation channel
which is stimulated by temperatures below 28°C and by
the cooling agents Menthol and Icilin [18,19].
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It is well established that TRPM8 channel expression is
regulated by androgens. Indeed, the androgen regulation
of TRPM8 expression was reported in prostate cancer
and putative androgen receptor response elements were
identified in the TRPM8 gene [20-22]. Therefore, TRPM8
channels can be considered as a valuable prognostic
marker in prostate cancer [23]. However, in breast cancer,
TRPM8 function and regulation by E2 are unknown. Only
a single report has mentioned the over-expression of
TRPM8 mRNA in breast cancer [17].
It is now well established that breast cancer cell line
MCF-7 expresses E2 receptors (ER+), and that 17-β-estra-
diol increases its proliferation [24]. In the present study,
we examined the expression and function of TRPM8 in
the ER+ human breast cancer cell line MCF-7. We also
determined whether TRPM8 mRNA expression was reg-
ulated by estrogens. Finally, we investigated whether
TRPM8 is over-expressed in human breast cancer tissues
regarding their ER status.
Methods
Cell culture and steroid depletion procedure
MCF-7 cells were routinely cultured in Dulbecco's Modi-
fied Eagle's Medium (Lonza, Belgium) including 4.5 g/L
glucose and L-glutamine, supplemented with 5% fetal calf
serum (FCS), and maintained at 37°C in a humidified
atmosphere with 5% CO2. For steroid depletion experi-
ments, MCF-7 cells were seeded in 60-mm Petri dishes at
a density of 6.105 cells/dish and grown for 48 h. Then,
cells were grown in a medium in which the FCS was
replaced with starvation medium (0FCS) or steroid-free
medium (5% dextran-coated charcoal-treated FCS
(DCCFCS) for 24, 48 and 72 h prior to incubation with E2
(10 nM) for 24 and 48 h E2 (Sigma, France) was dissolved
in ethanol, and final E2 concentration was obtained by
appropriate dilution. The dilution factor was < 1/100000.
Electrophysiological recording
MCF-7 cells were seeded in 35-mm Petri dishes at a con-
fluence of 8.104 cells/dish. They were grown at 37°C in a
humidified atmosphere of air/CO2 for further 48 h before
electrophysiological recordings. Dishes with attached
cells were transferred to a continually perfused recording
chamber and TRPM8 activity was recorded using the
conventional patch clamp technique in the whole cell
configuration. Patch pipettes were made using haemat-
ocrit capillaries (Hirschmann-Laborgerate, Germany.
Patch pipettes of 3-5 MΩ were filled with (in mM): CsCl
145, NaCl 8, MgCl2 2, EGTA 10, and HEPES 10 (pH was
adjusted to 7.2 using CsOH). External solution for patch-
clamp recordings contained (in mM): NaCl 140, KCl 5,
CaCl2 2, MgCl2 2, HEPES 10, Glucose 5, and TEA-Cl 5
(pH was adjusted to 7.4 using NaOH). Activation of
TRPM8 currents was achieved by external application of
20 μM Icilin. Current-Voltage relationship was obtained
by linear 100 ms ramps from -100 mV to +100 mV from a
holding potential of -40 mV. Signals were captured using
a Digidata 1200 converter and they were analysed using
an Axopatch 200B in combination with pClamp 9 soft-
ware (All from Molecular Devices, Sunnyvale, CA, USA).
Traces were filtered at 5 kHz and digitized at 10 kHz.
Analyses were made using Clampfit 9 (Molecular
Devices, Sunnyvale, CA, USA) and Microcal Origin 8.0
software (Microcal Software, Northampton, MA, USA).
Experiments were performed at room temperature
(21°C).
Calcium imaging
Calcium imaging experiments, using Fura-2, have been
carried out as previously described [25]. The extracellular
solution contained (in mM): 145 NaCl, 5 KCl, 5 CaCl2, 2
MgCl2, 10 HEPES, and 5 glucose (pH adjusted to 7.4 by
NaOH). Icilin and thapsigargin (TG, Sigma Aldrich,
France) were dissolved in DMSO. The dilution factor was
< 1/1000.
Reverse transcription and semi-quantitative PCR
Total RNA extraction and reverse transcription of RNA
was carried out as previously described [15]. Sense and
antisense PCR primers specific to TRPM8 channels
(sense: 5'-TCTACGAGCCCTACCTG-3', antisense: 5'-
CACCGTGTAGCCAAAC-3'), ERα (sense: 5'-AGGTG-
TACCTGGACAGCAGCAAG-3', antisense: 5'-TCTA-
GAAGGTGGACCTGATCATG-3'), and β-actin (sense:
5'-CAGAGCAAGAGAGGCATCCT-3', antisense: 5'-
ACGTACATGGCTGGGGTG-3') were used. PCR reac-
tions were carried out on a iCycler thermal cycler (Bio-
rad, France) using the following parameters: denaturation
at 94°C for 30 s, annealing at 58°C (TRPM8 and β-actin)
or 60°C (ERα) for 30 s, and extension at 72°C for 40 s. 23
cycles for β-actin and 40 cycles for TRPM8 and ERα
primers were performed, followed by an extension at
72°C for 5 min. PCR products were analyzed by gel elec-
trophoresis and visualized by ethidium bromide staining.
PCR products were quantified using Quantity One soft-
ware (Biorad, France) and results are expressed as the
ratio of ERα or TRPM8 on β-actin referent gene.
Small Interfering (si) RNA cell transfection
MCF-7 cells were transfected as previously described [26]
using 2 μg ERα siRNA (SiERα) on target plus smart pool
L-003401-00-0005 human ESR1 (Dharmacon, USA).
Control experiments were performed by transfecting 2 μg
siRNA (SiControl) which does not target any known gene
(D-001210-01-20, Dharmacon, USA).Chodon et al. BMC Cancer 2010, 10:212
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Immunoprecipitation and Western Blotting
MCF-7 cells were lysed in RIPA buffer (Triton X-100 1%,
sodium deoxycholate 1%, NaCl 150 mM, Tris HCl 50 mM
pH 7.4, Sigma P8340 inhibitors cocktail, EDTA 2 mM,
sodium orthovanadate 0.5 mM). Human colon cancer tis-
sue proteins were extracted in the WCE buffer (Whole
Cell Extract: NaCl 150 mM, Tris HCl 50 mM pH7.5,
NP40 1%, Sigma P8340 inhibitors cocktail, SDS 0.1% and
sodium orthovanadate 1 mM) using a Polytron homoge-
nizer (PRO-200, Fisher Bioblock Scientific). Equal
amount of each protein sample (30 μg) were separated by
electrophoresis on SDS-PAGE and blotted onto nitrocel-
lulose membrane (GE Healthcare). Blots were incubated
as indicated with antibodies raised against TRPM8
(Abcam, 1/500) and β-actin (Santa Cruz, 1/2000) pro-
teins. The blots were developed with the enhanced
chemiluminescence (ECL) system (Bio-rad) using specific
peroxidase-conjugated anti-IgG antibodies.
Immunoprecipitation experiments were performed on
1 mg of protein sample from MCF-7 cells. Lysates were
precleared 30 min with 50 μl of protein G- and A-agarose
beads. Supernatants were incubated overnight at 4°C
with 1 μg of TRPM8 antibody (Abcam) and then incu-
bated with protein G- and A-agarose beads for 30 min.
Beads were washed three times with RIPA buffer and
resuspended in SDS loading buffer before electrophore-
sis.
Immuno-histochemistry
Tumour and non-tumour tissue samples were selected by
pathologists from fresh specimens and embedded in par-
affin until analysis. Surgical consent forms were signed by
the patients to allow the use of a portion of the cancerous
tissue for research purposes. Samples were considered as
ER+ when ERα was expressed. ERα immuno-histochemi-
cal staining (ER+ or ER-) and tumour grade were evalu-
ated by the pathologists in routine examination. The
Scarff, Bloom and Richardson (SBR) histopronostic grad-
ing system is based on cell differentiation, nuclear poly-
morphism and mitotic activity: Grade I (well-
differentiated), Grade II (moderately-differentiated) and
Grade III (poorly-differentiated).
TRPM8 immuno-histochemical studies were per-
formed as previously described [15] using the indirect
immuno-peroxidase staining technique on paraffin-
embedded material with a Ventana ES automatic analyzer
(Ventana Medical Systems) and with a haematoxylin
counterstain. Briefly, after blocking the endogenous per-
oxidase by the I-View Inhibitor (Ventana), sections were
stained with an anti-TRPM8 antibody (Abcam, 1/1500),
incubated with biotinylated anti-rabbit IgG (I-View Bio-
tin Ig, Ventana) and exposed to streptavidine-peroxidase
complex (I-View SA-HRP, Ventana). DAB/H2O2 was used
as chromogen and the slides were then examined under
optical microscopy. Micrograph acquisition was per-
formed by a camera connected to a Zeiss microscope
equipped with a x 20 objective lens. Immuno-staining
levels in the tumour tissue were determined by subjective
visual scoring of the brown stain, and compared to the
non tumoral tissue. Scoring levels were: 0 = absence of
staining; 1 = weak staining intensity (equal to normal tis-
sue); 2 = moderate; 3 = strong staining intensity. For the
quantitative analysis, we report the percentage of cases
presenting an over-expression of TRPM8 (scores 2 and 3).
All experiments on human tissues were approved by
the Comité Consultatif de Protection des Personnes dans
la Recherche Biomédicale de Picardie (CCPPRB),
Amiens, France.
Statistics
Results are expressed as means ± SEM. Unpaired Student
t-tests were used for mRNA expression levels analysis. χ2
tests were used to estimate the significance between the
effects of Icilin on the Ca2+ signal in E2 treated cells, and
also to estimate the correlation between TRPM8 over-
expression and adenocarcinomas ER status. Differences
were considered significant when p < 0.05.
Results
Evidence of functional TRPM8 channels in MCF-7 breast 
cancer cell line
In order to examine whether TRPM8 channels are
expressed in MCF-7 cells, RT-PCR and Western Blotting
experiments were carried out (Fig. 1). We detected
TRPM8 mRNA in MCF-7 cells, and in human colon can-
cer tissue which was used as a positive control (Fig. 1A).
TRPM8 proteins were also observed in human colon can-
cer tissue and in a lesser extent in MCF-7 cells (Fig. 1B,
lanes 1-2). Immunoprecipitation experiments using the
same Abcam antibody confirmed the presence of TRPM8
proteins in MCF-7 cells (Fig. 1B, lane 3).
Whole cell currents were elicited by a 100 ms linear
ramp from -100 mV to +100 mV from a holding potential
of -40 mV (Fig. 2A, insert: upper panel), and were
recorded at steady state 2 ± 1 minutes after the patch rup-
ture. After 3 ± 1 minutes, cells were perfused with a solu-
tion containing 20 μM of Icilin, the potent activator of
TRPM8. Icilin activated a "noisy" non-selective current
with a strong outward rectification (Fig. 2A). The cur-
rent-density recorded in the presence of Icilin in the bath
was markedly higher than before Icilin perfusion (43.42 ±
12.60 pA/pF vs 5.94 ± 1.77 pA/pF at +100 mV). The
reversal potential was 8.29 ± 4.30 mV in the presence of
Icilin. However, Icilin induced a response in only 4/14
cells (28.6% of all the cells tested). Fig. 2A (insert, lower
panel) shows the Icilin-activated current which is calcu-
lated by substracting the control current from the current
recorded after Icilin application.Chodon et al. BMC Cancer 2010, 10:212
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To further characterize TRPM8 channels in MCF-7
cells, calcium imaging experiments were performed. Per-
fusion of Icilin at a concentration of 20 μM, in an external
solution containing 5 mM Ca2+ caused a sustained eleva-
tion of cytoplasmic calcium concentration [Ca2+]c (Fig.
2B). The proportion of responsive cells was only 32.16%
of cells tested (64/199 of all the cells tested). TRPM8 pro-
tein can be present in the plasma membrane and in the
endoplasmic reticulum of human prostate LNCaP cancer
cell line [20]. Moreover, high concentrations of menthol
in the absence of extracellular Ca2+ caused a small but sig-
nificant increase in intracellular Ca2+ in LNCaP cells [20].
To test whether TRPM8 channels are functional at endo-
plasmic reticulum (ER), cells were perfused with 20 μM
Icilin in the absence of external Ca2+. In this condition,
Icilin had no effect, while application of the most potent
selective SERCA inhibitor Thapsigargin (1 μM), which is
often used to induce Ca2+ release from endoplasmic retic-
ulum, increased intracellular Ca2+ in MCF-7 cells (Fig.
2C, n = 20). Taken together, these results show that MCF-
7 cells express functional TRPM8 channels at the plasma
Figure 1 Analysis of TRPM8 mRNA and protein expression in 
MCF-7 cells. (A) RT-PCR analysis of human TRPM8 transcripts expres-
sion in MCF-7 cells on three independent cell lysates. Human colon ex-
tract was used as positive control for the detection of TRPM8. (B) 
Western blot analysis of TRPM8 proteins were performed on total 
lysate (lanes 1-2) of two independent cell extracts, or after immunopre-
cipitation experiment (lane 3). The arrow indicates a TRPM8 band, and 
(*) a non specific band.
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Figure 2 Icilin activated functional plasma membrane TRPM8 
channel in MCF-7 breast cancer cell line. (A) Averaged I-V relation-
ship of membrane current-densities in MCF-7 cells before and after ap-
plication of Icilin (20 μM) in the bath (n = 4). Upper panel represents the 
patch-clamp protocol and lower panel the Icilin-activated current. 
Whole cell currents were elicited by a 100 ms linear ramp from -100 mV 
to +100 mV from a holding potential of -40 mV. (B) Average time-
course of [Ca2+]c variation measured as fluorescence at 340/380 nm ra-
tio (n = 11). (C) Average time-course of [Ca2+]c changes (n = 20) during 
perfusion of 20 μM Icilin and 1 μM TG in the absence of extracellular 
Ca2+.
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membrane, and not at the endoplasmic reticulum mem-
brane.
17-β estradiol enhanced TRPM8 expression in a steroid-
deprived MCF-7 cells
In order to determine whether the human TRPM8 was
regulated by estrogens, we cultured MCF-7 cells in
starved medium (0 FCS) or steroid-free medium (5% dex-
tran-coated charcoal-treated FCS (DCCFCS). Incubation
of MCF-7 cells in DCCFCS induced a significant decrease
in TRPM8 mRNA level by 76 ± 8.4% of the control for 48
h and 71.1 ± 6.8% of the control for 72 h (p < 0.01, Fig.
3A). As 17-β estradiol (E2) is known to be the main physi-
ological steroid in the breast, we studied the effects of
adding E2 on TRPM8 expression in MCF-7 cells cultured
under steroid-free conditions. After incubation in
DCCFCS medium for 48 h, MCF-7 cells were stimulated
with E2 (10 nM) for 24 h and 48 h. TRPM8 mRNA expres-
sion increased after 24 h (219.4 ± 6.7% of control, p <
0.05) and 48 h (298.3 ± 30.2% of control, p < 0.01) of incu-
bation with E2 (Fig. 3Ba). We observed similar results
using 0FCS medium with an increase of incubation with
E2 after 24 h (350.1 ± 123.3% of control) and 48 h (303.6 ±
76.7% of control, p < 0.05) (Fig. 3Bb).
We then investigated the consequences of the E2 treat-
ment on the Ca2+ signal induced by Icilin. Fig. 3C showed
that after 48 h starvation, stimulation of MCF-7 cells with
E2 (10 nM) for 24 h failed to affect both the number of
cells responding to Icilin (48/205 in 0FCS vs. 66/299 in
0FCS+E2), and the amplitude of Ca2+ entry induced by
Icilin (ΔR = 0.16 ± 0.02, n = 48 in 0FCS vs. ΔR = 0.15 ±
0.02, n = 66 in 0FCS+E2). However, E2 treatment for 48 h
increased the number of cells which respond to Icilin (47/
388 in 0FCS vs. 103/437 in 0FCS+E2, p < 0.001, Fig. 3C),
without a significant change in the amount of Icilin-
induced Ca2+ entry (ΔR = 0.14 ± 0.01, n = 47 in 0FCS vs.
ΔR = 0.16 ± 0.01, n = 103 in 0FCS+E2, Fig. 3C).
TRPM8 expression is regulated by ERα in human MCF-7 
cells and correlated with ER status in breast 
adenocarcinomas
The dependence of TRPM8 expression on the presence of
ERα was studied using small interfering RNA to knock-
down ERα. After siRNA-ERα transfection, MCF-7 cells
were cultured in complete medium for 72 h. RT-PCR
experiments confirmed that ERα was reduced by 44 ±
7.5% of the control (p < 0.01) and that TRPM8 mRNA
expression decreased by 47 ± 5.5% of the control (p <
0.001) (Fig. 4).
We then examined the expression of TRPM8 channels
in human tumoral and adjacent non-tumoral breast tis-
sues. Immuno-histochemical study showed a stronger
cytosolic TRPM8 staining in cancerous epithelial cells
(Fig. 5B) than in their non-tumoral counterpart (Fig. 5A).
Statistical analysis revealed that the over-expression of
TRPM8 in tumoral tissues was observed in 65.4% of the
26 ductal adenocarcinomas tested. To confirm ERα regu-
lation of TRPM8 in a physiological context, we studied
Figure 3 TRPM8 mRNA expression is under hormonal control. (A) 
Upper panel: agarose gel showing TRPM8 mRNA expression in MCF-7 
cells which were incubated in steroid-free FCS medium (DCCFCS) for 
24, 48 and 72 h. Lower panel: histogram showing a decrease of TRPM8 
mRNA expression in DCCFCS medium (*, p < 0.05, three independent 
experiments). (B. a) Upper panel: a representative experiment showing 
TRPM8 mRNA expression in MCF-7 cells which were incubated in DC-
CFCS medium for 48 h prior to E2 (10 nM) application for 24 and 48 h. 
Lower panel: histogram showing that E2 increased TRPM8 mRNA ex-
pression (*, p < 0.05, **, p < 0.01, four independent experiments). (B. b) 
Upper panel shows an agarose gel representative of the effect of E2 on 
TRPM8 expression. MCF-7 cells were growing in 0FCS medium for 48 h 
prior to added E2 (10 nM) for 24 h and 48 h. Lower panel: histogram 
showing that E2 increased TRPM8 mRNA levels (*, p < 0.05, three inde-
pendent experiments). TRPM8 mRNA levels are expressed as the ratio 
of TRPM8 on β-actin referent gene. (C) Histograms showing the aver-
age of cells sensitive to Icilin (left panel) and the average of the ampli-
tude of Icilin-induced Ca2+ entry (right panel) in MCF-7 cells -incubated 
in 0FCS for 48 h prior to E2 (10 nM) application for 24 and 48 h (***, p < 
0.001, three independent experiments).
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the correlation between the over-expression of TRPM8
and ERα expression on breast cancer tissues samples. We
found that TRPM8 over-expression was observed in
77.8% of the ERα positive tumours and in 37.5% of the
ERα negative tumours (p < 0.05, Table 1), suggesting an
association between TRPM8 expression and ER+ status.
Because one of the parameters used in the SBR grading
system is the cell differentiation, we investigated whether
the TRPM8 expression varied with tumour grades. Our
results show that in the ER+  adenocarcinomas which
over-expressed TRPM8, 42.8% (6/14) were grade I, 42.8%
(6/14) were grade II and 14.2% (2/14) were grade III.
These results suggest that the TRPM8 expression
depending on the differentiation status.
Discussion
In this study, we demonstrate that: 1) MCF-7 breast can-
cer cell line expressed a classical Icilin-sensitive channel,
2) Icilin induced also an increase of intracellular Ca2+ that
was mediated by endogenous plasma membrane TRPM8
activation, 3) only 30% of cells under investigation
respond to Icilin, 4) expression of TRPM8 is regulated by
estrogens, and 5) the over-expression of TRPM8 in breast
adenocarcinomas is correlated with ER+ status.
Functional TRPM8 channels have been clearly charac-
terized in over-expression systems [18,19], in human can-
cer epithelial LNCaP cell line [20], and in primary culture
of prostate epithelium cancer (PrPCa) cells [27]. Both
cold and Menthol activated an inward current in LNCaP
cell line [28], while Icilin activated a classical outwardly
rectified TRPM8-current in PrPCa cells [22,27]. In MCF-
7 cells, application of the super-cooling agent Icilin,
which is ~200-fold more potent than menthol, activated
both an outwardly rectifying current and an elevation of
cytoplasmic Ca2+ in a small fraction of cells (30% of all the
cells tested). In cells responding to Icilin, the activated
currents were characterized by an outward rectification
and a reversal potential close to 0 mV as described in the
literature for plasma membrane TRPM8 evoked currents
[22,27]. The small proportion of responding cells suggest
that TRPM8 channels are not widely functionally
expressed in the MCF-7 breast cancer line.
In LNCaP cells, two studies have reported dual local-
ization of TRPM8 channels in the plasma membrane
(PMTRPM8) and endoplasmic reticulum (ERTRPM8). Pre-
varskaya's group has demonstrated that the ERTRPM8 is a
truncated TRPM8 isoform which acts as an endoplasmic
reticulum calcium releasing channel and which is not
regulated by differentiation status [27,29]. In contrast,
PMTRPM8 channels are regulated by the differentiation
and androgen receptor status [27,29]. Indeed, PMTRPM8
is fully expressed and functional in the early stages of
well-differentiated androgen-dependent prostate cancer,
and disappeared in metastasis profile when androgen
receptors down-regulate. MCF-7 cell line was isolated
from a non invasive adenocarcinoma, and retains several
characteristics of differentiated mammary epithelium
including the sensibility to estradiol via estrogen recep-
tors and the capability of forming domes [30]. Moreover,
when analysing the expression of TRPM8 according to
b r e a s t  c a n c e r  g r a d e s ,  w e  f o u n d  t h a t  T R P M 8  i s  r a t h e r
over-expressed in grade I (well differentiated) and II
(moderately differentiated) than in grade III (poorly dif-
ferentiated). Taken together, we can suggest that in breast
cancer, TRPM8 is functional at the plasma membrane
Figure 4 Silencing ERα reduced TRPM8 mRNA expression. (A) 
Agarose gel showing ERα and TRPM8 mRNAs expression in MCF-7 cells 
72 h after transfection with SiERα. (B) Histogram showing that ERα si-
lencing reduced TRPM8 mRNA expression (**, p < 0.01, ***, p < 0.001, 
three independent experiments). TRPM8 and ERα mRNA levels are ex-
pressed as the ratio of TRPM8 or ERα on β-actin referent gene.
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Figure 5 Over-expression of TRPM8 in breast adenocarcinomas. 
Immuno-histochemical staining using a specific anti-TRPM8 antibody 
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and expressed in the early primitive breast cancers pre-
senting a well-differentiated status.
Several studies have provided evidence of a pro-
nounced TRPM8 expression in human tumours including
prostate cancer, melanoma, lung cancer, colorectal ade-
nocarcinoma and breast cancer [17,22,31]. Our results
show, for the first time, that TRPM8 protein is over-
expressed in human breast adenocarcinomas and that
this over-expression is specifically correlated with ERα
expression. Furthermore, in ER+ MCF-7 cell line, TRPM8
expression is regulated by estrogens. Indeed, either ER
expression silencing or E2 deprivation led to a reduction
in TRPM8 mRNA expression, and application of E2
increased TRPM8 mRNA. Moreover, stimulation of
starved cells with E2  increased the number of cells
responding to Icilin without altering the amount of Icilin-
induced Ca2+ entry, suggesting that estrogens control the
fraction of cells expressing TRPM8 channels rather than
the amount of TRPM8 channel per cell. Taken together,
these results suggest a hormonal-dependent regulation of
TRPM8 expression in breast cancer. Regulation of
TRPM8 by androgens in prostate cancer cells was sug-
gested by Tsavaler et al [17] and confirmed in LNCaP cell
line [20,22]. In LNCaP cells, the analysis of the TRPM8
gene resulted in the detection of 10 putative androgen
responsive elements, one in the promoter region and the
others in introns of the gene [20,22]. Altogether, we can
suggest that TRPM8 gene expression is under steroid
hormones regulation. However, in breast cancer, the reg-
ulation of TRPM8 gene expression by putative estrogen
response elements needs further investigations.
Conclusion
In conclusion, we have shown that TRPM8 is expressed
and functional in breast cancer MCF-7 cell line. Further-
m o r e ,  w e  h a v e  p r o v i d e d  e v i d e n c e  o f  E R  m e d i a t e d
increase in TRPM8 mRNA expression. Finally, we have
found a correlation between TRPM8 expression in
tumour tissues and ERα expression.
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